Last reviewed · How we verify

NCT04499469

The Role of Spreader Grafts in Reduction Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life Assessment

Status unknown NA Last updated 5 August 2020
What this trial tests

NA trial testing Spreader Graft in Rhinoplasty in 50 participants. Status unknown.

Timeline
3 October 2018
Primary endpoint
1 March 2021
1 June 2021

Quick facts

Lead sponsorHospital de Clinicas de Porto Alegre
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment50
Start date3 October 2018
Primary completion1 March 2021
Estimated completion1 June 2021
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Hospital de Clinicas de Porto Alegre

Who can join

Adults 14 to 80, any sex, with Rhinoplasty or Nasal Obstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nasal obstruction is one of the majors concerns in reduction rhinoseptoplasty, because it affects quality of life and surgical outcomes. Is the association of middle third grafts with reduction rhinoseptoplasty responsible for an increase in quality of life related to nasal obstruction when compared to reduction rhinoseptoplasty without the placement of these grafts?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rhinoplasty

Currently open trials in the same condition.

Other Hospital de Clinicas de Porto Alegre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04499469.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing